Every resource the GPCR ecosystem has ever produced.

Explore the assays and frameworks for measuring GPCR internalization — from beta-arrestin gating to endosomal signaling, recycling, and degradation. A structured session inside Terry’s Corner by Dr. Terry Kenakin.

Study targeting orphan platelet GPCR OR2L13 as novel antithrombotic strategy; high-throughput screen identified non-odorant compounds that reduce platelet reactivity via actin cytoskeleton remodeling.

GPCR internalization does not end signaling — it redirects it. This article explores the assays, beta-arrestin gating mechanisms, and recycling-versus-degradation frameworks that determine receptor fate inside the cell.

Bryan Roth joins the Dr. GPCR community live this week to examine what standard models don't account for — what happens when GPCR selectivity is encoded at the receptor–transducer interface rather than the receptor alone.

Review of glucagon signaling mechanisms beyond glycemic control, covering effects on amino acid, lipid, and energy metabolism, with implications for glucagon-based pharmacotherapy.

Reveals structural and molecular mechanisms underlying GqPCR regulation of TASK K2P channels via DAG binding, explaining pathogenic effects linked to K2P channelopathies.

Reveals xanthine oxidase-dependent H2O2 role in GPCR agonist-induced ABCA1 destabilization via COP9 signalosome disruption and cullin3-mediated ubiquitination, promoting foam cell formation.

​

​

​

​

​